just doubled my holdings, page-2

I'm going back to the announcement made by the company on March 30, announcing the appointment of Julius Matthys to the position of interim CEO. Quote: "Julius will commence as interim CEO with effect from Monday 3 April 2017 beginning with a review of Quintis' operations and outlook". I emphasise: REVIEW of QUINTIS' OPERATIONS AND OUTLOOK".
If, in more than a month of reviewing the situation, the only announcement made was the one about the Galderma contract, perhaps there's room for very, very, VERY CAUTIOUS optimism.